A transgenic mouse model for in vivo regulation of the human CYP3A4 promoter

被引：0
|
作者：
Zhang, WS [1 ]
Purchio, A [1 ]
Chen, K [1 ]
Wu, JM [1 ]
Lu, L [1 ]
West, DB [1 ]
机构：
[1] Xenogen Corp, Alameda, CA 94501 USA
来源：
DRUG METABOLISM REVIEWS | 2002年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
235
引用
收藏
页码：118 / 118
页数：1
相关论文
共 50 条
  • [11] The Effect of microRNAs in the Regulation of Human CYP3A4: a Systematic Study using a Mathematical Model
    Wei, Zhiyun
    Jiang, Songshan
    Zhang, Yiting
    Wang, Xiaofei
    Peng, Xueling
    Meng, Chunjie
    Liu, Yichen
    Wang, Honglian
    Guo, Luo
    Qin, Shengying
    He, Lin
    Shao, Fengmin
    Zhang, Lirong
    Xing, Qinghe
    SCIENTIFIC REPORTS, 2014, 4
  • [12] The Effect of microRNAs in the Regulation of Human CYP3A4: a Systematic Study using a Mathematical Model
    Zhiyun Wei
    Songshan Jiang
    Yiting Zhang
    Xiaofei Wang
    Xueling Peng
    Chunjie Meng
    Yichen Liu
    Honglian Wang
    Luo Guo
    Shengying Qin
    Lin He
    Fengmin Shao
    Lirong Zhang
    Qinghe Xing
    Scientific Reports, 4
  • [13] Regulation of the human CYP3A4 gene in lung cells.
    Biggs, JS
    Yost, GS
    TOXICOLOGICAL SCIENCES, 2003, 72 : 118 - 118
  • [14] Utility of CYP3A4 and PXR-CAR-CYP3A4/3A7 Transgenic Mouse Models To Assess the Magnitude of CYP3A4 Mediated Drug-Drug Interactions
    Ly, Justin Q.
    Messick, Kirsten
    Qin, Ann
    Takahashi, Ryan H.
    Choo, Edna F.
    MOLECULAR PHARMACEUTICS, 2017, 14 (05) : 1754 - 1759
  • [15] Time-dependent inhibition of CYP3A4 by mibefradil in recombinant CYP3A4 and human liver microsomes and impact on in vivo predictions
    Burt, Howard
    Galetin, Aleksandra
    Houston, Brian
    DRUG METABOLISM REVIEWS, 2006, 38 : 47 - 48
  • [16] GLOBAL ANALYSIS OF CYP3A4 AND CYP3A5 GENOTYPE ON IN VIVO CLEARANCE OF CYP3A4 SUBSTRATES.
    Quinney, S. K.
    Schwartz, J. B.
    Hall, S. D.
    Gorski, J. C.
    Li, L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S49 - S49
  • [17] Differential regulation of CYP3A4 and CYP3A7 by dimethylsulfoxide in primary human hepatocytes
    Wilkening, S
    Bader, A
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2004, 95 (02) : 92 - 93
  • [18] Differential regulation of human CYP3A4 and CYP3A5 genes in lung cells
    Biggs, JS
    Yost, GS
    DRUG METABOLISM REVIEWS, 2002, 34 : 26 - 26
  • [19] Regulation of human CYP3A4 and CYP3A5 genes in lung cells.
    Biggs, JS
    Raunio, H
    Hakkola, J
    Pelkonen, O
    Yost, GS
    FASEB JOURNAL, 2002, 16 (04): : A180 - A180
  • [20] Predictiveness of the Human-CYP3A4-Transgenic Mouse Model (Cyp3aXAV) for Human Drug Exposure of CYP3A4-Metabolized Drugs
    Damoiseaux, David
    Li, Wenlong
    Martinez-Chavez, Alejandra
    Beijnen, Jos H.
    Schinkel, Alfred H.
    Huitema, Alwin D. R.
    Dorlo, Thomas P. C.
    PHARMACEUTICALS, 2022, 15 (07)
12345